Resnick, Chodorow & Associates

Resnick, Chodorow & AssociatesResnick, Chodorow & AssociatesResnick, Chodorow & Associates
  • Home
  • About Us
  • Services
  • Research Topics
  • Clients
  • Projects
  • Contact Us
  • More
    • Home
    • About Us
    • Services
    • Research Topics
    • Clients
    • Projects
    • Contact Us

Resnick, Chodorow & Associates

Resnick, Chodorow & AssociatesResnick, Chodorow & AssociatesResnick, Chodorow & Associates
  • Home
  • About Us
  • Services
  • Research Topics
  • Clients
  • Projects
  • Contact Us

Research Topics

Our projects have addressed these health conditions:

  • Alzheimer's disease
  • Amyloidosis
  • Asthma
  • Bladder cancer
  • Cognitive function
  • COVID-19
  • Crohn's disease/ulcerative colitis
  • Cystic fibrosis
  • Diabetes
  • Duchenne muscular dystrophy
  • Epidermolysis bullosa
  • Gaucher disease
  • Hearing loss
  • Heart failure
  • Hemophilia
  • Hepatitis C
  • HIV
  • HPV
  • Hypercholesterolemia
  • Juvenille idiopathic arthritis
  • Melanoma
  • Mucopolysaccharidosis
  • Multiple sclerosis
  • Pachyonychia congenita
  • Prader-Willi syndrome
  • Prostate cancer
  • Scleroderma
  • Systemic lupus erythematosus
  • Rheumatoid arthritis

We have worked in these topic areas:

  • Access to prescription medications
  • Accessible workplace technologies 
  • Aging and disability
  • Aging services technologies
  • Clinical inertia
  • Computerized cognitive assessment
  • Cost sharing
  • Cost of treatment
  • Direct-to-consumer pharmaceutical advertising
  • Elder abuse
  • Food insecurity
  • Gene editing
  • Healthcare access
  • Health impact of the built environment
  • Health information technology
  • Hispanic health
  • Long term care
  • Medicare Advantage
  • Medicare/Medicaid dual eligibles
  • Medicare Part D
  • Medicare's Low Income Subsidy Program
  • Medication adherence
  • Medication errors
  • Microhematuria screening
  • Noise exposure
  • Nutrition support
  • Opioids
  • Otolaryngology 
  • Out-of-pocket drug costs
  • Patient assistance programs
  • Patient-reported outcome measures
  • Pediatric drug policy
  • Pharmaceutical choice
  • Screening
  • Social determinants of health
  • Specialty medications
  • Step therapy policies
  • Surgical outcomes in venous disease
  • Telehealth
  • Trust in science
  • Urogynecology 
  • Vaccine hesitancy 

Copyright © 2018 Resnick, Chodorow & Associates - All Rights Reserved.